Scott analyzes the sudden emergence of commercial trait-based embryo selection services, discussing both the scientific validity and ethical implications of selecting embryos for health outcomes, intelligence, and physical traits. Longer summary

Scott examines the recent development of commercial embryo selection services, particularly focusing on companies like Genomic Prediction, Orchid Health, Nucleus, and Herasight. He explains how the technology works, comparing different companies' claims and methodologies, and discusses both scientific challenges and ethical concerns. The post explores the potential benefits, like reduced disease risk and increased IQ, while acknowledging issues around cost, racial disparities, and social implications. A significant portion focuses on Herasight's critique of competitor Nucleus's scientific claims. The post concludes by placing this technology in the broader context of human enhancement and future technological developments. Shorter summary

Scott Alexander grades his 2018 predictions for 2023 and makes new predictions for 2028, with a strong focus on AI developments. Longer summary

Scott Alexander reviews his predictions from 2018 for 2023, grading himself on accuracy across various domains including AI, world affairs, US culture and politics, economics, science/technology, and existential risks. He then offers new predictions for 2028, focusing heavily on AI developments and their potential impacts on society, economics, and politics. Shorter summary

Scott Alexander examines obscure pregnancy interventions that may improve child outcomes, rating them by evidence quality and potential impact. Longer summary

Scott Alexander reviews various obscure pregnancy interventions that could potentially improve child outcomes, particularly IQ. He rates them in tiers based on evidence strength and potential impact, with Tier 1 being most strongly supported. Key interventions discussed include embryo selection, choline supplementation, avoiding stress and certain substances, and optimizing birth timing. He emphasizes these are extreme measures not meant to induce guilt, and that standard pregnancy advice is still most important. Shorter summary

Scott Alexander discusses the birth of the first polygenically-screened baby and explores the current and potential future applications of this technology in IVF. Longer summary

Scott Alexander discusses the birth of the first polygenically-screened baby, explaining the process of in vitro fertilization (IVF) and how polygenic screening works. He describes how this technology can be used to reduce the risk of genetic diseases and potentially select for other traits. The post covers the current capabilities of polygenic screening, its potential future applications, and some ethical considerations. Scott also mentions the first polygenically screened baby, named Aurea, born to a family with a history of breast cancer. Shorter summary